
PSB Financial, Inc.
82
Recent news coverage includes market and commodity price movements relevant to the broader financial environment but does not provide direct updates on PSB Financial's business.
- Soybeans posted midday losses despite record NOPA crush, reflecting volatility in agricultural commodity markets [N1].
- Montauk (MNTK) released its Q3 2026 earnings call transcript, providing insights into sector peers [N2].
- Rising Indian sugar production is weighing on prices, indicating shifts in global commodity supply [N3].
- Cementos Pacasmayo S.A.A. board approved an amended tender offer report following regulator observations [N4].
- Enlivex Therapeutics Ltd. entered into a securities purchase agreement for a $7.5 million registered direct offering [N5].
- ANI Pharmaceuticals, Inc. detailed an offer to acquire Egetis Therapeutics for SEK 5.6 billion [N6].
- The US dollar fell on weak retail sales and consumer sentiment reports, impacting financial markets [N7].
- An analysis comparing Amazon and Microsoft as AI investment opportunities was published, reflecting technology sector dynamics [N8].
PSB Financial, Inc. is a smaller reporting company that files quarterly financial statements with the SEC. The company reported a net loss and negative earnings per share for the third quarter of 2026. It maintains a cash position of over $24 million as of the end of Q3 2026. The company is not listed on any stock exchange and does not have publicly disclosed sector or industry classifications in the available data. Recent news coverage does not provide direct updates on PSB Financial's business operations but includes broader market and commodity price information.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. PSB Financial, Inc. filed a 10-Q on November 16, 2026, reporting cash and cash equivalents of $24.3 million and a net loss of $33,913 for the quarter ended September 30, 2026. Basic and diluted EPS were negative $0.02. The company has 1,719,250 shares outstanding and is a smaller reporting company not listed on any exchange [S1].
The company maintains a solid cash position relative to its size, which may provide operational flexibility. Its status as a smaller reporting company could allow for nimble management and focused strategic initiatives. The availability of detailed quarterly financial disclosures supports transparency for stakeholders.
PSB Financial reported a net loss and negative earnings per share for the latest quarter, indicating challenges in profitability. The lack of exchange listing and limited public information on business segments or industry exposure may constrain investor visibility and liquidity. Absence of detailed business model disclosures increases uncertainty about growth drivers and risk factors.
Information on PSB Financial's competitive advantages or moat is not disclosed in the available SEC filings or recent news. The company operates as a smaller reporting entity without exchange listing, which may limit public visibility into its business model and competitive positioning.
• Profitability Risk: The company reported a net loss and negative EPS for the quarter ended September 30, 2026, indicating ongoing challenges in generating profits.
• Liquidity and Market Access Risk: PSB Financial is not listed on any exchange and is classified as a smaller reporting company, which may limit access to capital markets and reduce liquidity for shareholders.
• Information Transparency Risk: Limited disclosure of sector, industry, and detailed business operations restricts external understanding of the company's competitive positioning and strategic direction.
Business trends: The company continues to report quarterly financials with a net loss and maintains a cash reserve, reflecting ongoing operational challenges and liquidity management.
Execution milestones: Timely SEC filings and maintenance of cash balances demonstrate compliance and financial stewardship.
Key risks: Profitability challenges, limited market access due to lack of exchange listing, and restricted transparency on business operations.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- PSB Financial, Inc. is a reporting company with a recent 10-Q filing dated November 16, 2026, covering the quarter ended September 30, 2026 [S1].
- As of September 30, 2026, PSB Financial had cash and cash equivalents of $24,322,000 USD [S1].
- The company reported a net loss of $33,913 USD for the quarter ended September 30, 2026 [S1].
- Basic and diluted earnings per share were both negative $0.02 USD for the same period [S1].
- As of November 16, 2026, PSB Financial had 1,719,250 shares outstanding [S1].
- The company is not listed on any exchange and is classified as a non-accelerated filer and smaller reporting company [S1].
- No sector or industry classification is provided in the available data.
- Recent news items relevant to the company or its market environment include agricultural commodity price movements and earnings call transcripts of other companies, but no direct business updates for PSB Financial were found [N1][N2][N3][N4][N5][N6][N7][N8].
Generated 2026-11-17
- S1 | 2026-11-16 | 10-Q
- N1 | 2026-11-16 | www.nasdaq.com | Soybeans Posting Midday Losses, Despite Record NOPA Crush | https://www.nasdaq.com/articles/soybeans-posting-midday-losses-despite-record-nopa-crush
- N2 | 2026-11-16 | www.nasdaq.com | Montauk (MNTK) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/montauk-mntk-q3-2026-earnings-call-transcript
- N3 | 2026-11-16 | www.nasdaq.com | Rising Indian Sugar Production Weighs on Prices | https://www.nasdaq.com/articles/rising-indian-sugar-production-weighs-prices
- N4 | 2026-11-16 | www.nasdaq.com | Cementos Pacasmayo S.A.A. Board Approves Amended Tender Offer Report Following Regulator Observations | https://www.nasdaq.com/articles/cementos-pacasmayo-saa-board-approves-amended-tender-offer-report-following-regulator
- N5 | 2026-11-16 | www.nasdaq.com | Enlivex Therapeutics Ltd. Enters into Securities Purchase Agreement for $7,500,000 Registered Direct Offering | https://www.nasdaq.com/articles/enlivex-therapeutics-ltd-enters-securities-purchase-agreement-7500000-registered-direct
- N6 | 2026-11-16 | www.nasdaq.com | ANI Pharmaceuticals, Inc. Details Offer to Acquire Egetis Therapeutics for SEK 5.6B | https://www.nasdaq.com/articles/ani-pharmaceuticals-inc-details-offer-acquire-egetis-therapeutics-sek-56b
- N7 | 2026-08-16 | www.nasdaq.com | Dollar Falls on Weak US Retail Sales and Consumer Sentiment Reports | https://www.nasdaq.com/articles/dollar-falls-weak-us-retail-sales-and-consumer-sentiment-reports-0
- N8 | 2026-08-16 | www.nasdaq.com | Amazon vs. Microsoft: Which Cloud Computing Behemoth Is the Better Artificial Intelligence (AI) Buy Today? | https://www.nasdaq.com/articles/amazon-vs-microsoft-which-cloud-computing-behemoth-better-artificial-intelligence-ai-buy
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


